MK-677 vs GHRP-6
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Ibutamoren, Nutrobal
MK-677 (ibutamoren) is not actually a peptide, it is a small, orally active non-peptide molecule that mimics ghrelin, your hunger and growth-hormone hormone. Taken as a daily pill, it reliably pushes up growth hormone and IGF-1 levels, which is why it is popular for muscle and recovery. It has been through real human trials but was never approved as a drug, and the trials that mattered most for older adults and Alzheimer's came up short.
Also: Growth Hormone Releasing Peptide 6, SKF-110679
GHRP-6 is a synthetic six-amino-acid peptide (His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) that tricks the body into releasing its own growth hormone. It was one of the first growth hormone secretagogues ever made, and the hunt to find out why it worked led scientists straight to the discovery of ghrelin. It has no approval as a drug anywhere and is used only as a research compound.
Key Comparison Insights
- Both peptides belong to the Growth Hormone category, suggesting similar primary applications.
Detailed Comparison
| Attribute | MK-677 | GHRP-6 |
|---|---|---|
| Category | Growth Hormone | Growth Hormone |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | MK-677 is a selective agonist of the growth hormone secretagogue receptor (GHS-R1a), the same receptor the hormone ghrelin binds. By activating that receptor in the pituitary and hypothalamus, it triggers pulses of growth hormone release, which in turn raises IGF-1 (insulin-like growth factor 1) from the liver. Because it copies ghrelin, it also tends to increase appetite, and it can nudge up cortisol levels too. The effect is sustained because it is long-acting and orally available, unlike injectable peptides that mimic ghrelin or growth-hormone-releasing hormone. | GHRP-6 binds and activates the growth hormone secretagogue receptor type 1a (GHS-R1a), the same receptor later found to be the natural target of the hunger hormone ghrelin. When it switches that receptor on in the pituitary and hypothalamus, the pituitary fires off a pulse of growth hormone. Because GHS-R1a also sits on appetite-driving neurons in the brain (the NPY/AgRP cells of the arcuate nucleus), GHRP-6 is a strong appetite stimulant, more so than the other GHRPs. At higher doses it also nudges up cortisol and prolactin, since the receptor system is not perfectly selective for the GH pathway. |
| Common Dosing | 10-25 mg daily Once daily, often before bed | 100-300 mcg 2-3x daily 2-3x daily |
| Administration | Oral | Subcutaneous injection, ideally fasted |
| Typical Duration | 8-12 weeks or longer | 8-12 weeks |
| Best Time to Take | Before bed | Before bed or morning (fasted) |
Possible Side Effects May vary by individual |
|
|
| Research Summary | MK-677 has unusually good human data for a compound sold in the gray market, and the data is a mix of clear wins and clear failures. In a one-year randomized trial of 65 healthy older adults (Annals of Internal Medicine, 2008), 25 mg daily raised IGF-1 and increased fat-free mass, basically lean tissue, though much of the early body-weight gain was water and the functional strength benefits were not impressive. In Alzheimer's disease, a large 563-patient, 12-month randomized trial (Neurology, 2008) confirmed it raised IGF-1 but did nothing to slow cognitive decline. Across studies the consistent downsides are increased appetite, fluid retention, and reduced insulin sensitivity (higher blood sugar). So the muscle-and-IGF-1 effect is real and well documented, but MK-677 failed its biggest disease trials, remains unapproved, and is banned in sport by WADA. | GHRP-6 has been studied in humans, but mostly as a lab and diagnostic probe rather than as a treatment with large clinical trials behind it. Early work in the 1980s and 1990s showed it reliably triggers growth hormone release, and chasing its mechanism is literally what led Kojima and colleagues to discover ghrelin in 1999, which reframed how we understand hunger and GH control. A 2013 pharmacokinetic study in nine healthy men found oral bioavailability under 1 percent and an elimination half-life around 2.5 hours, which is why it is given by injection. The popular claims about muscle gain, fat loss, and healing in fitness circles are not backed by controlled human outcome trials. It is not approved by the FDA or EMA for any use and remains a research chemical, with appetite stimulation, water retention, and cortisol/prolactin bumps as known effects. |
Frequently Asked Questions: MK-677 vs GHRP-6
What is the difference between MK-677 and GHRP-6?
MK-677 is a growth hormone peptide that mk-677 (ibutamoren) is not actually a peptide, it is a small, orally active non-peptide molecule that mimics ghrelin, your hunger and growth-hormone hormone. taken as a daily pill, it reliably pushes up growth hormone and igf-1 levels, which is why it is popular for muscle and recovery. it has been through real human trials but was never approved as a drug, and the trials that mattered most for older adults and alzheimer's came up short. GHRP-6 is a growth hormone peptide that ghrp-6 is a synthetic six-amino-acid peptide (his-d-trp-ala-trp-d-phe-lys-nh2) that tricks the body into releasing its own growth hormone. it was one of the first growth hormone secretagogues ever made, and the hunt to find out why it worked led scientists straight to the discovery of ghrelin. it has no approval as a drug anywhere and is used only as a research compound. The main differences lie in their mechanisms of action and clinical applications.
Which is better, MK-677 or GHRP-6?
Neither is universally "better" - the choice depends on your specific goals. MK-677 is typically used for growth hormone purposes, while GHRP-6 is used for growth hormone. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can MK-677 and GHRP-6 be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using MK-677 and GHRP-6 together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.